Data / Form D filings / Restora Medical, Inc.
Restora Medical, Inc.: Form D filings
Restora Medical, Inc., a biotechnology company in Irvine, CA, filed 6 Form D notices with the SEC between 2024 and 2026. The latest, on June 18, 2026, reports $11.5 million sold of a $15 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2603 MAIN ST. SUITE 770, Irvine, CA, 92614
- Phone
- (949) 932-0243
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2008412
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Amendment | $15,000,000 | $11,500,000 | $3,500,000 | 5 | May 18, 2026 | sec.gov |
| Jun 18, 2026 | Amendment | $12,049,999 | $6,024,999 | $6,025,000 | 11 | Feb 19, 2025 | sec.gov |
| Jun 18, 2026 | Amendment | $7,400,000 | $3,500,000 | $3,900,000 | 4 | Jan 8, 2024 | sec.gov |
| May 29, 2026 | New notice | $15,000,000 | $11,500,000 | $3,500,000 | 5 | May 18, 2026 | sec.gov |
| Mar 6, 2025 | New notice | $12,049,999 | $6,024,999 | $6,025,000 | 11 | Feb 19, 2025 | sec.gov |
| Jan 23, 2024 | New notice | $7,400,000 | $3,500,000 | $3,900,000 | 4 | Jan 8, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Quan Ni | Executive Officer, Director, Promoter | |
| Chau Khuong | Director | |
| Tianji Zhu | Director | |
| Ye Zhang | Director | |
| Lixiao Wang | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 15, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Restora Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.